glp-1 obesity drugs updates today Research shows are effective but complex GLP-1 Pipeline Update: August 2025

How Akkermansia supports the gut barrier What sets Akkermansia apart is where it works

May help diabetes

The table lists thrombocytopenia and clotting disorders as high-risk because of reduced platelet count or factor deficiency, and connective tissue disorders for vascular fragility and collagen defects

"Building on the well-established profile of semaglutide and combining it with a novel mechanism of action, CagriSema has the potential to represent a meaningful step forward in the holistic treatment of obesity

These drugs have become so popular that prescription fills increased by more than 400% between January 2021 and December 2023